drugset / Trial / NCT00463047

Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain

NCT00463047

Phase 3 Completed 323 enrolled Cephalon
RandomizedCrossoverDouble-blindTreatment

Summary

Evaluate the efficacy of treatment with Fentanyl Buccal Tablets (FBT) compared with immediate release oxycodone in alleviating breakthrough pain in opioid tolerant patients with chronic pain.

Timeline

Start
2007-07
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 200 ug Other
Subject Fentanyl Other / unclassified 400 ug Other
Subject Fentanyl Other / unclassified 600 ug Other
Subject Fentanyl Other / unclassified 800 ug Other
Subject Oxycodone Other / unclassified 15 mg
Subject Oxycodone Other / unclassified 30 mg
Subject Oxycodone Other / unclassified 45 mg
Subject Oxycodone Other / unclassified 60 mg

Indications